Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yonghao Zhan

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of Experimental & Clinical Cancer Research : CR|January 9, 2016
Synthetic Bax-Anti Bcl2 combination module actuated by super artificial hTERT promoter selectively inhibits malignant phenotypes of bladder cancerLi Liu, Yuchen Liu, Tianbiao Zhang, et al.
Urologic Oncology|June 3, 2019
Prognostic performance of the 1973 and 2004 WHO grading classification in upper tract urothelial carcinomaBao Guan, Shiying Tang, Yonghao Zhan, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 2, 2024
CT-based conventional radiomics and quantification of intratumoral heterogeneity for predicting benign and malignant renal lesionsShuanbao Yu, Yang Yang, Zeyuan Wang, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 20, 2022
Laparoscopic placement of left renal vein extravascular stenting in treatment of nutcracker syndrome: Techniques and long-term outcomesShuanbao Yu, Jinshan Cui, Junxiao Liu, et al.
Cancer Letters|March 29, 2016
Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancerMingwei Chen, Chengle Zhuang, Yuchen Liu, et al.
Oncotarget|March 28, 2018
Positive urinary fluorescence <i>in situ</i> hybridization indicates poor prognosis in patients with upper tract urothelial carcinomaBao Guan, Yicong Du, Xiaohong Su, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 23, 2016
Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancerJianfa Li, Chengle Zhuang, Yuchen Liu, et al.
Oncotarget|April 2, 2016
Inhibiting cell migration and cell invasion by silencing the transcription factor ETS-1 in human bladder cancerLi Liu, Yuchen Liu, Xintao Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 28, 2023
Correction: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancerJianfa Li, Chengle Zhuang, Yuchen Liu, et al.
Clinical Epigenetics|July 15, 2018
Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancerDing Peng, Guangzhe Ge, Yanqing Gong, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of Experimental & Clinical Cancer Research : CR|January 9, 2016
Synthetic Bax-Anti Bcl2 combination module actuated by super artificial hTERT promoter selectively inhibits malignant phenotypes of bladder cancerLi Liu, Yuchen Liu, Tianbiao Zhang, et al.
Urologic Oncology|June 3, 2019
Prognostic performance of the 1973 and 2004 WHO grading classification in upper tract urothelial carcinomaBao Guan, Shiying Tang, Yonghao Zhan, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|October 2, 2024
CT-based conventional radiomics and quantification of intratumoral heterogeneity for predicting benign and malignant renal lesionsShuanbao Yu, Yang Yang, Zeyuan Wang, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 20, 2022
Laparoscopic placement of left renal vein extravascular stenting in treatment of nutcracker syndrome: Techniques and long-term outcomesShuanbao Yu, Jinshan Cui, Junxiao Liu, et al.
Cancer Letters|March 29, 2016
Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancerMingwei Chen, Chengle Zhuang, Yuchen Liu, et al.
Oncotarget|March 28, 2018
Positive urinary fluorescence <i>in situ</i> hybridization indicates poor prognosis in patients with upper tract urothelial carcinomaBao Guan, Yicong Du, Xiaohong Su, et al.
Journal of Experimental & Clinical Cancer Research : CR|June 23, 2016
Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancerJianfa Li, Chengle Zhuang, Yuchen Liu, et al.
Oncotarget|April 2, 2016
Inhibiting cell migration and cell invasion by silencing the transcription factor ETS-1 in human bladder cancerLi Liu, Yuchen Liu, Xintao Zhang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 28, 2023
Correction: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancerJianfa Li, Chengle Zhuang, Yuchen Liu, et al.
Clinical Epigenetics|July 15, 2018
Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancerDing Peng, Guangzhe Ge, Yanqing Gong, et al.
Pageof 7